Interests in associates - Summarized statement of comprehensive income (Details) - EUR (€) € in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Interests in associates | |||
| Revenue | € 19,627,602 | € 19,335,909 | € 19,453,617 |
| Profit for the period | 1,191,267 | 740,870 | 732,458 |
| Other comprehensive income | (1,466,407) | 715,902 | (630,011) |
| Total comprehensive income | (275,140) | 1,456,772 | € 102,447 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | |||
| Interests in associates | |||
| Revenue | 950,888 | 741,183 | |
| Profit from continuing operations | 456,306 | 290,766 | |
| Profit for the period | 456,306 | 290,766 | |
| Other comprehensive income | (3,428) | (116,914) | |
| Total comprehensive income | 452,878 | 173,852 | |
| Dividends received | € 137,174 | € 92,386 | |
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The cash inflow representing dividends received from investments that are accounted for using the equity method, classified as investing activities. [Refer: Investments accounted for using equity method; Dividends received] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|